drugset / Trial / NCT03927651

ICG to Assess Ovarian Perfusion

NCT03927651 ↗

Phase 0 Completed 54 enrolled Northwestern University
NaSingle-groupOpen-labelDiagnostic

Summary

To assess the feasibility of using intravenous ICG to characterize the vascular perfusion of ovaries during gynecologic surgery

Timeline

Start
2019-06-01
Primary completion
2022-11-15
Completion
2022-11-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Indocyanine green (ICG) Unknown — Intravenous